Rui Kang
- Cancer Research top 0.01%
- Cancer, Lipids, and Metabolism 39
- Pulmonary and Respiratory Medicine top 0.01%
- Ferroptosis and cancer prognosis 105
- Clinical Biochemistry top 0.02%
- Advanced Glycation End Products research 57
- Molecular Biology top 0.05%
- RNA modifications and cancer 56
- Inflammasome and immune disorders 25
- Epigenetics and DNA Methylation 21
- Immunology top 0.1%
- Immune Response and Inflammation 22
-
- Autophagy in Disease and Therapy 47
- Co-authors
- Daolin TangGuido KroemerXin ChenMichael T. LotzeHerbert J. ZehDaniel J. KlionskyJiao LiuYangchun Xie
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (7 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Rui Kang
265 papers receiving 46.2k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Cancer Research 17.5k
- Pulmonary and Respiratory Medicine 23.4k
- Clinical Biochemistry 4.0k
- Molecular Biology 27.6k
- Immunology 7.2k
Countries citing papers authored by Rui Kang
This map shows the geographic impact of Rui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Kang more than expected).
Fields of papers citing papers by Rui Kang
This network shows the impact of papers produced by Rui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Kang. The network helps show where Rui Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 24 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 36 | |
| 6 | 2023 | 10 | |
| 7 | Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancerbreakdown → | 2023 | 171 |
| 8 | 2023 | 19 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 26 | |
| 11 | 2022 | 47 | |
| 12 | 2021 | 84 | |
| 13 | 2019 | 116 | |
| 14 | HSPA5 Regulates Ferroptotic Cell Death in Cancer Cellsbreakdown → | 2017 | 447 |
| 15 | 2016 | 40 | |
| 16 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsbreakdown → | 2015 | 1566 |
| 17 | 2013 | 2 | |
| 18 | 2013 | 1 | |
| 19 | Analysis of storage stability of accelerometers | 2013 | 1 |
| 20 | 2012 | 220 |
About Rui Kang
Rui Kang is a scholar working on Clinical Biochemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 280 papers that have together received 46.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (105 papers), Advanced Glycation End Products research (57 papers), RNA modifications and cancer (56 papers), Autophagy in Disease and Therapy (47 papers), Cancer, Lipids, and Metabolism (39 papers), Inflammasome and immune disorders (25 papers), Immune Response and Inflammation (22 papers) and Epigenetics and DNA Methylation (21 papers). The work is most often cited by research in Cancer Research (17.5k citations), Pulmonary and Respiratory Medicine (23.4k citations) and Clinical Biochemistry (4.0k citations). Rui Kang has collaborated with scholars based in United States, China and France. Frequent co-authors include Daolin Tang, Guido Kroemer, Xin Chen, Michael T. Lotze, Herbert J. Zeh, Daniel J. Klionsky, Jiao Liu, Yangchun Xie, Xinxin Song and Xiaofang Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.